Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1982-6-21
pubmed:abstractText
Affinity chromatography-purified and non-purified rabbit immunoglobulin G (IgG) raised against human immunoglobulin M (IgM) or kappa chain was incorporated into carboxyfluorescein-containing small unilamellar liposomes composed of egg phosphatidylcholine, cholesterol and phosphatidic acid (molar proportions 7:7:1). IgG incorporation was carried out by co-sonicating the immunoglobulin with the lipids (30% incorporated) (method A) or by interacting it with preformed liposomes bearing goat anti-(rabbit IgG) IgG (63 and 70% incorporated) (method B). (1) Judging from liposomal carboxyfluorescein-latency values, incorporation of IgG by either method did not affect liposomal stability. Furthermore, treatment of liposomes with papain released 75.1% (method A) and 93.3% and 95.1% (method B) of the IgG, suggesting that most of its antigen-recognizing Fab regions were available on the liposomal surface. This was strongly supported by the immunoelectrophoretic detection of Fab in papain-released products. (2) Liposomes bearing purified anti-IgM IgG bound 30%, (method A) and 45% (method B) of IgM in buffer. These values wee about 6-fold greater (both methods) than those obtained with corresponding liposomes bearing non-purified IgG. Binding of liposomes bearing anti-(kappa chain) IgG to kappa chain in buffer was 37% of that added. In the presence of mouse blood or serum, binding of IgM to liposomes bearing purified anti-IgM IgG was decreased slightly (24 and 30% for methods A and B). However, because of the nearly complete abolition of IgM binding to liposomes bearing non-purified IgG, these values were now 20-25-fold greater than those obtained with liposomes bearing non-purified IgG. (3) In mice pre-injected with IgM, at least 36.1% and 37.7% of the antigen was bound to subsequently injected liposomes bearing anti-IgM IgG incorporated by methods A and B respectively. No binding occurred with liposomes bearing the non-purified IgG. (4) Cholesterol-rich small unilamellar liposomes bearing affinity chromatography-purified antibodies may prove useful for the specific binding of free antigens in vivo.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-1054517, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-1272396, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-13262900, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-187181, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-205346, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-210837, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-217405, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-4434987, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-4646772, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-486550, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-496958, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-50067, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-5305881, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-571288, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-6056841, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-6159929, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-6176223, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-6254563, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-63397, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-6933450, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7001454, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-70733, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7207015, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7213898, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7358175, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7378067, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7408883, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7410345, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7423203, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7428926, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-7442804, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-804521, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-835007, http://linkedlifedata.com/resource/pubmed/commentcorrection/6803776-857912
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
200
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
203-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors.
pubmed:publicationType
Journal Article